BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10395732)

  • 1. Mutations in the N-terminal regulatory region reduce the catalytic activity of Csk, but do not affect its recognition of Src.
    Sun G; Budde RJ
    Arch Biochem Biophys; 1999 Jul; 367(2):167-72. PubMed ID: 10395732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subdomain switching reveals regions that harbor substrate specificity and regulatory properties of protein tyrosine kinases.
    Wang YH; Huang K; Lin X; Sun G
    Biochemistry; 2007 Sep; 46(35):10162-9. PubMed ID: 17691821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine residues in the C-terminal lobe of Src: their role in the suppression of the Src kinase.
    Oo ML; Senga T; Thant AA; Amin AR; Huang P; Mon NN; Hamaguchi M
    Oncogene; 2003 Mar; 22(9):1411-7. PubMed ID: 12618767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
    Koegl M; Courtneidge SA; Superti-Furga G
    Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src protein-tyrosine kinase structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1155-64. PubMed ID: 15504335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic coupling between the SH2 domain and active site of the COOH terminal Src kinase, Csk.
    Wong L; Lieser S; Chie-Leon B; Miyashita O; Aubol B; Shaffer J; Onuchic JN; Jennings PA; Woods VL; Adams JA
    J Mol Biol; 2004 Jul; 341(1):93-106. PubMed ID: 15312765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of autophosphorylation on the catalytic and regulatory properties of protein tyrosine kinase Src.
    Sun G; Ramdas L; Wang W; Vinci J; McMurray J; Budde RJ
    Arch Biochem Biophys; 2002 Jan; 397(1):11-7. PubMed ID: 11747305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of N-terminal lobe motifs that determine the kinase activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine kinases.
    Huang K; Wang YH; Brown A; Sun G
    J Mol Biol; 2009 Mar; 386(4):1066-77. PubMed ID: 19244618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.